Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top ten pharmaceutical merger and acquisition deals by value 2014

Top 10 pharmaceutical merger and acquisition deals worldwide by value in 2014 (in billion U.S. dollars)*

by Statista Research Department, last edited Jun 15, 2015
Top ten pharmaceutical merger and acquisition deals by value 2014 This statistic describes the top 10 merger and acquisition deals worldwide within the pharmaceutical industry in 2014, based on deal value. In that year, Roche acquired InterMune in a deal valued at 8.3 billion U.S. dollars. Merger and acquisitions become more common as cash-rich companies aim to reorganize their companies.
Show more

Top 10 pharmaceutical merger and acquisition deals worldwide by value in 2014 (in billion U.S. dollars)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Eli Lilly"
  • Global positioning
The most important statistics
  • Revenue and income
  • Expenses
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.